Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2021 · 10-Q
Revenue$224.25M$224.25M+21.3% vs Q2 2020 Net Income$46.27M$46.27M−61.3% vs Q2 2020 EPS Diluted$1.15$1.15−61.9% vs Q2 2020 Gross Profit$150,900,000+24.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$89,269,000+26.8% Free Cash Flowderived$77,824,000+39.3% Margins · derivedGross margin67.3%+1.6 pt vs Q2 2020
Operating margin22.7%+2.7 pt vs Q2 2020
Net margin20.6%−44.0 pt vs Q2 2020
ended Dec 31, 2020 · filed Feb 8, 2021 · 39 d after period end